Your browser doesn't support javascript.
loading
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups.
Pieters, Rob; de Groot-Kruseman, Hester; Fiocco, Marta; Verwer, Femke; Van Overveld, Merian; Sonneveld, Edwin; van der Velden, Vincent; Beverloo, H Berna; Bierings, Marc; Dors, Natasja; de Haas, Valérie; Hoogerbrugge, Peter; Van der Sluis, Inge; Tissing, Wim; Veening, Margreet; Boer, Judith; Den Boer, Monique.
Afiliação
  • Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • de Groot-Kruseman H; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
  • Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Verwer F; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
  • Van Overveld M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Sonneveld E; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
  • van der Velden V; Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands.
  • Beverloo HB; Mathematical Institute, Leiden University, Leiden, the Netherlands.
  • Bierings M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Dors N; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
  • de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Hoogerbrugge P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Van der Sluis I; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
  • Tissing W; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.
  • Veening M; Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands.
  • Boer J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Den Boer M; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.
J Clin Oncol ; 41(25): 4130-4142, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37459571

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article